Ciprofloxacin And Fluocinolone Acetonide
Product Images NDC 42195-128

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Fluocinolone Acetonide (NDC 42195-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xspire Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure-ciprofloxin (Figure 01)

FDA Label Image

Chemical Structure-fluocinolone Acetonide (Figure 02)

FDA Label Image

Image (Figure 03)

FDA Label Image

Image (Figure 04)

FDA Label Image

Image (Figure 05)

FDA Label Image

Image (Figure 06)

FDA Label Image

Image (Figure 07)

FDA Label Image

Image (Figure 08)

FDA Label Image

Image (Figure 09)

FDA Label Image

Image (Figure 10)

FDA Label Image

Image (Figure 11)

FDA Label Image

Principal Display Panel (0.25 mL Vial Pouch Carton)

Principal Display Panel (0.25 mL Vial Pouch Carton)
This is a prescription medication containing two active ingredients- Fluocinolone Acetonide 0.025% and Ciprofloxacin0.3% in otic solution form. The product is distributed by a company (Pharia, LLC) and made in Spain. The package includes a warning to discard the vial after use and keep out of reach of children. The U.S. patent number is 8932610.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.